Lanadelumab for the prevention of hereditary angioedema attacks: A
real-world UK audit.
- Anthony Dorr,
- Charu Chopra,
- Tanya Coulter I,
- John Dempster,
- Magdalena Dziadzio,
- Tariq El-Shanawany,
- Tomaz Garcez
, - Mark Gompels,
- Richard Herriot,
- Rashmi Jain,
- Marcel Levi,
- Lorena Lorenzo,
- Inas Makki,
- Elizabeth Mapazire,
- Sai Murng,
- Sadia Noorani,
- Sinisa Savic,
- Cathal L. Steele,
- Christine Symons,
- Michael Tarzi,
- Patrick Yong,
- Sorena Kiani-Alikhan
Anthony Dorr
Barts Health NHS Trust
Corresponding Author:anthony.dorr@nhs.net
Author ProfileRashmi Jain
Oxford University Hospitals NHS Foundation Trust
Author ProfileSai Murng
Epsom and Saint Helier University Hospitals NHS Trust
Author ProfileSadia Noorani
Sandwell and West Birmingham Hospitals NHS Trust
Author Profile12 Sep 2022Submitted to Allergy 12 Sep 2022Submission Checks Completed
12 Sep 2022Assigned to Editor
12 Sep 2022Reviewer(s) Assigned
01 Oct 2022Review(s) Completed, Editorial Evaluation Pending
23 Nov 20221st Revision Received
24 Nov 2022Submission Checks Completed
24 Nov 2022Assigned to Editor
24 Nov 2022Review(s) Completed, Editorial Evaluation Pending
28 Nov 2022Reviewer(s) Assigned
08 Dec 2022Editorial Decision: Accept
